They also experience improved comfort and mobility compared to standard single-ingredient creams or oral regimens
NICE guidance (NG28) recommends GLP-1 receptor agonists as a treatment option for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is not effective, not tolerated or contraindicated The person has a BMI of 35 kg/m or higher (adjust accordingly for people from particular ethnic groups) and specific psychological or other medical problems associated with obesity The person has a BMI lower than 35 kg/m and insulin would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities GLP-1 receptor agonists may also be considered in combination with insulin therapy in specialist care settings Beyond glycaemic control, specific GLP-1 receptor agonists offer significant cardiovascular benefits
On 9 November 2025, news reports highlighted a frightening incident that has gone viral
GLP-1 receptor agonist therapies remain costly, resource-intensive, and often require specialist oversight
Badanie 7: Jedyne opublikowane dane kliniczne na ludziach Cytat: Veljaca M., Pavic Sladoljev D., Mildner B., et al
Keep away from naked flame or direct heat sources
